1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Differences between patients presenting with and without END
END (n = 9) No END (n = 26) P Men (No.) (%) 6 (66.7) 17 (65.4) .944 Age (mean) (SD) (yr) 72.56 (13.78) 72.12 (12.74) .931 Prior antiplatelet therapy (No.) (%) 4 (44.4) 2 (8.3) .017 Prior anticoagulant therapy (No.) (%) 1 (11.1) 3 (12.5) .913 Systolic BP at admission (mean) (SD) (mm Hg) 166.63 (37.82) 168.64 (31.77) .885 Blood glucose level at admission (mean) (SD) (mg/dL) 152.13 (23.09) 133.06 (52.78) .334 Platelet count/mm3 at admission (mean) (SD) 240,000 (87,311) 213,958 (72,678) .41 Baseline HV measured with CT (median) (IQR) (mL) 97.14 (35.9–118.8) 6.85 (1.96–34.13) .002 Baseline MLS measured with CT (median) (IQR) (cm) 0.59 (0–1.38) 0 (0–0.24) .018 Significant HG assessed with CT (No.) (%)a 1 (33.3) 1 (6.3) .298 Baseline HV measured with TDS (median) (IQR) (mL) 46.48 (29.83–75.21) 8.62 (4.08–20.38) .001 Baseline MLS measured wit TDS (median) (IQR) (cm) 0.31 (0.3–1.36) 0.09 (0.05–0.2) .007 Pulsatility index from the ipsilateral MCA (mean) (SD) (cm/s) 1.47 (0.5) 1.19 (0.31) .162 Pulsatility index from the contralateral MCA (mean) (SD) (cm/s) 1.33 (0.34) 1.12 (0.28) .073 Lobar localization (No.) (%) 6 (66.7) 10 (38.5) .245 IVH (No.) (%) 4 (44.4) 6 (23.1) .393
Note:—BP indicates blood pressure; HG, hematoma growth.
↵a Analysis was restricted to 21 patients for whom a follow-up CT was available.